Table 1: PFTs Before and After Anti-MAC Treatment

Pt RX FEV1 FVC FEV1/FVC TLC FRC DLCO
% pd Δ % pd Δ % pd Δ % pd Δ % pd Δ % pd Δ
1 post 70 13 80 4 77 11 106 3 134 -21 71 4
pre 59 76 66 103 155 67
2 post 75 13 86 8 71 7 109 6 142 -25 100 16
pre 62 78 64 103 167 84
3 post 87 17 100 15 74 5 132 5 139 -9 106 27
pre 70 85 69 127 148 79
4 post 36 11 75 16 38 5
pre 25 59 33
5 post 62 6 79 5 64 5
pre 56 74 59
6 post 79 9 105 17 64 -3
pre 70 88 67
7 post 88 2 77 -5 84 -1
pre 86 82 85
8 post 79 -9 90 -11 67 0
pre 88 101 67
9 post 66 0 74 3 85 13 85 9 92 31 84 -5
pre 66 77 73 73 61 89
10 post 51 3 77 11 56 -1 144 4 184 4 42 -8
pre 48 66 57 140 180 50
Mean ↑ 10.29 10.86 7.67
SD 4.72 5.34 3.50
p 0.001 0.09 0.42

Mean, SD, p values reported for increases in patients with abnormal PFTs.Pt = Patient number, RX = Anti-MAC therapy, Post = Post treatment, Pre = Pre-treatmenr, %pd = Percent predicted, Δ = Change from pre and post values, ↑ = Increase, SD = Standard deviation, p = Probability.